ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

ClinicalTrials.gov ID: NCT00676650

Public ClinicalTrials.gov record NCT00676650. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 8:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen

Study identification

NCT ID
NCT00676650
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
873 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Prednisone Drug
  • sunitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2008
Primary completion
Nov 30, 2011
Completion
Nov 30, 2011
Last update posted
Mar 7, 2013

2008 – 2011

United States locations

U.S. sites
87
U.S. states
24
U.S. cities
76
Facility City State ZIP Site status
Pfizer Investigational Site Decatur Alabama 35601
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Huntsville Alabama 35805
Pfizer Investigational Site Anaheim California 92801
Pfizer Investigational Site Encinitas California 92024
Pfizer Investigational Site Glendale California 91206
Pfizer Investigational Site La Jolla California 92037
Pfizer Investigational Site Los Angeles California 90033
Pfizer Investigational Site Modesto California 95355
Pfizer Investigational Site Thousand Oaks California 91360
Pfizer Investigational Site Thousands Oaks California 91360
Pfizer Investigational Site Vista California 92083
Pfizer Investigational Site Westlake Village California 91361
Pfizer Investigational Site Denver Colorado 80205
Pfizer Investigational Site Lafayette Colorado 80025
Pfizer Investigational Site Gainesville Florida 32605
Pfizer Investigational Site Orlando Florida 32806
Pfizer Investigational Site Winter Park Florida 32789
Pfizer Investigational Site Arlington Heights Illinois 60005
Pfizer Investigational Site Niles Illinois 60714
Pfizer Investigational Site Winfield Illinois 60190
Pfizer Investigational Site Zion Illinois 60099
Pfizer Investigational Site Carmel Indiana 46032
Pfizer Investigational Site Fishers Indiana 46037
Pfizer Investigational Site Greenfield Indiana 46140
Pfizer Investigational Site Indianapolis Indiana 46219
Pfizer Investigational Site Indianapolis Indiana 46227
Pfizer Investigational Site Lafayette Indiana 47905
Pfizer Investigational Site Louisville Kentucky 40207
Pfizer Investigational Site Baltimore Maryland 21201
Pfizer Investigational Site Boston Massachusetts 02114
Pfizer Investigational Site Danvers Massachusetts 01923
Pfizer Investigational Site Minneapolis Minnesota 55455
Pfizer Investigational Site Saint Cloud Minnesota 56303-5000
Pfizer Investigational Site Corinth Mississippi 38834
Pfizer Investigational Site Southaven Mississippi 38671
Pfizer Investigational Site Lincoln Nebraska 68506
Pfizer Investigational Site Omaha Nebraska 68114
Pfizer Investigational Site Henderson Nevada 89052
Pfizer Investigational Site Henderson Nevada 89074
Pfizer Investigational Site Las Vegas Nevada 89128
Pfizer Investigational Site Las Vegas Nevada 89148
Pfizer Investigational Site Las Vegas Nevada 89169
Pfizer Investigational Site Sewell New Jersey 08080
Pfizer Investigational Site New York New York 10032
Pfizer Investigational Site The Bronx New York 10461
Pfizer Investigational Site The Bronx New York 10467-2401
Pfizer Investigational Site Cary North Carolina 27518
Pfizer Investigational Site Durham North Carolina 27710
Pfizer Investigational Site Kernersville North Carolina 27284
Pfizer Investigational Site Lexington North Carolina 27295
Pfizer Investigational Site Mount Airy North Carolina 27030
Pfizer Investigational Site North Wilkesboro North Carolina 28659
Pfizer Investigational Site Raleigh North Carolina 27607
Pfizer Investigational Site Raleigh North Carolina 27614
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Bismarck North Dakota 58501
Pfizer Investigational Site Cleveland Ohio 44106
Pfizer Investigational Site Mayfield Heights Ohio 44124
Pfizer Investigational Site Mentor Ohio 44060
Pfizer Investigational Site Orange Ohio 44122
Pfizer Investigational Site Westlake Ohio 44145
Pfizer Investigational Site Eugene Oregon 97401
Pfizer Investigational Site Springfield Oregon 97477
Pfizer Investigational Site Clairton Pennsylvania 15025
Pfizer Investigational Site Greensburg Pennsylvania 15601
Pfizer Investigational Site Johnstown Pennsylvania 15901
Pfizer Investigational Site Kingston Pennsylvania 18704
Pfizer Investigational Site Lancaster Pennsylvania 17604
Pfizer Investigational Site Pittsburgh Pennsylvania 15215
Pfizer Investigational Site Pittsburgh Pennsylvania 15232
Pfizer Investigational Site Pittsburgh Pennsylvania 15237
Pfizer Investigational Site Pittsburgh Pennsylvania 15241
Pfizer Investigational Site Uniontown Pennsylvania 15401
Pfizer Investigational Site Wexford Pennsylvania 15090
Pfizer Investigational Site Brighton Tennessee 38011
Pfizer Investigational Site Memphis Tennessee 38104
Pfizer Investigational Site Memphis Tennessee 38120
Pfizer Investigational Site Arlington Texas 76014
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Fort Worth Texas 76177
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Webster Texas 77598
Pfizer Investigational Site Everett Washington 98201
Pfizer Investigational Site Monroe Washington 98272
Pfizer Investigational Site Seattle Washington 98101
Pfizer Investigational Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 118 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00676650, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2013 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00676650 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →